切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - eIF4F - Calcium-Activated Potassium (KCa) Channels - NMDA Receptors - 5-HT receptor

11件产品中的 1-10

页面
每页
清除全部
  1. (RS)-CPP
    B6214 (RS)-CPP
    Target: NMDA Receptors
    Summary: NMDA拮抗剂
      <25.22 mg/mL
  2. Spermidine trihydrochloride
    B6523 Spermidine trihydrochloride
    中文名: 三盐酸亚精胺
    Target: NMDA Receptors
    Summary: NMDA受体激动剂
      insoluble in DMSO
      ≥10 mg/mL
  3. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: eIF4E:eIF4G与eIF4E:4E-BP1相互作用的双重抑制剂
      ≥23.85 mg/mL
      insoluble in H2O
  4. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  5. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  6. (-)-MK 801
    B1627 (-)-MK 801
    Target: NMDA Receptors
    Summary: 有效的NMDA选择性拮抗剂
      ≥10.3 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  9. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  10. (+)-MK 801
    A3100 (+)-MK 801
    Target: NMDA Receptors
    Summary: NMDA拮抗剂
      ≥10.45 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页